Unique ID issued by UMIN | UMIN000001495 |
---|---|
Receipt number | R000001664 |
Scientific Title | Investigation of MDCT Plaque Assessment in patients receiving Cholesterol lowering with Pitavastatin (IMPACT) |
Date of disclosure of the study information | 2008/11/11 |
Last modified on | 2017/05/31 17:46:26 |
Investigation of MDCT Plaque Assessment in patients receiving Cholesterol lowering with Pitavastatin (IMPACT)
IMPACT
Investigation of MDCT Plaque Assessment in patients receiving Cholesterol lowering with Pitavastatin (IMPACT)
IMPACT
Japan |
Patients with non-calcified coronary plaque detected with MDCT
Cardiology | Radiology |
Others
NO
The effect of chelesterol lowering by pitavastatin on plaque CT value compared with control group
Efficacy
The comparison of the plaque CT value change between the groups
a. The relationship between plaque CT value and the cholesterol level.
b.The relationship between plaque CT value and the oxidative stress and inflamation marker.
c. The change of HbH1c between the groups
Interventional
Parallel
Randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
pitavastatin 2mg per day orally for 12 months.
Stopping smoking, life style change and increasing exercise are reccomended. When the decrease in cholesterol level is not satisfactory, plavastatin will be administered.
20 | years-old | <= |
90 | years-old | > |
Male and Female
1)Patients with coronary non-calcified plaques detected by MDCT
2)Patients with hypercholesterolemia as defined by any of the following criteria: i) TC >220 mg/dl; ii) LDL-C >140 mg/dl; iii) cholesterol-lowering treatment is necessary in accordance with the investigator's judgement when LDL-C >120 mg/dl or TC >200 mg/dl.
3) Patients 20 years or older at the time of their consent.
4) Patients giving written consent by their own volition after being provided sufficient explanation for participation in this clinical trial.
1)The stenosis at the lesion where the plaque CT value estimation planned is more than 90%(AHA criteria).
2)Patients who have undergone previous PCI on the lesion site where the evaluation of coronary plaque CT value is planned.
3)Patients who might undergo PCI on the lesion where the plaque planned for the estimation of the CT value is located.
4)Patients receiving lipid-lowering drugs (pitavastatin, atorvastatin, rosvastatin).
5)Patients with familial hypercholesterolemia.
6)Patients with cardiogenic shock.
7)Patients receiving cyclosporine.
8)Patients with any allergy to pitavastatin
9)Patients with any allergy to contrast medium
10)Patients with hepatobiliary disorders.
11)Pregnant women, women suspected of being pregnant, or lactating women.
12)Patients with renal disorders or undergoing dialysis.
13)Patients who are ineligible in the opinion of the investigator.
100
1st name | |
Middle name | |
Last name | Tomoko Nao |
Yamaguchi University Graduate School of Medicine
Cardiology
1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan
0836-22-2248
nao@yamaguchi-u.ac.jp
1st name | |
Middle name | |
Last name | Tomoko Nao |
Yamaguchi University Graduate School of Medicine
Cardiology
1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan
0836-22-2248
nao@yamaguchi-u.ac.jp
Yamaguchi University Graduate School of Medicine,Department of Medicine and Clinical Science
Yamaguchi University Graduate School of Medicine,Department of Medicine and Clinical Science
Self funding
NO
2008 | Year | 11 | Month | 11 | Day |
Published
Completed
2008 | Year | 09 | Month | 11 | Day |
2008 | Year | 10 | Month | 01 | Day |
2011 | Year | 07 | Month | 30 | Day |
2011 | Year | 07 | Month | 30 | Day |
2011 | Year | 07 | Month | 30 | Day |
2013 | Year | 12 | Month | 01 | Day |
2008 | Year | 11 | Month | 10 | Day |
2017 | Year | 05 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001664
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |